MatsukiyoCocokara & Co.
Stock Price Chart
2026/01/16 UpdatedPrice Trend
2026/01/16 UpdatedPrice & Trading Details
2026/01/16 UpdatedPRICE
TRADING
Analyst Recommendations 12 analysts
Updated 2026/01/11Shareholder Composition
Updated 2026/01/11Major Holders
Updated 2026/01/11| Institution | Ownership | Shares | Change |
|---|---|---|---|
|
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund
|
5.0M | -1.25% | |
|
-Price (T.Rowe) International Value Equity Trust
|
4.0M | -12.93% | |
|
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund
|
3.2M | +1.40% | |
|
T. ROWE PRICE Intl Fd.S, INC.-T. Rowe Price Intl Value Eqy. Fd.
|
3.1M | -0.27% | |
|
Columbia Fd.s Varbl Series TRT II-Columbia Varbl PORT. - Overseas Core
|
3.0M | +6.86% | |
|
College Retirement Equities Fd.-College Retirement Equities Fd. - Stoc
|
2.8M | +78.89% |
Dividend History 4Years Growth
Updated 2026/01/11| Year | Dividend | Change |
|---|---|---|
| 2025 | ¥47 | +14.6% |
| 2024 | ¥41 | +36.7% |
| 2023 | ¥30 | +20.0% |
| 2022 | ¥25 | +7.2% |
| 2021 | ¥23 | - |
Financial Performance
2026/01/11 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥729,969M | ¥951,247M | ¥1,022,531M | ¥1,061,626M |
| Gross Profit | ¥239,979M | ¥329,320M | ¥354,097M | ¥372,235M |
| Operating Income | ¥41,095M | ¥62,280M | ¥75,710M | ¥82,086M |
| Pretax Income | ¥49,374M | ¥64,961M | ¥81,303M | ¥83,958M |
| Net Income | ¥34,377M | ¥40,545M | ¥52,347M | ¥54,675M |
| EPS | ¥93.78 | ¥95.99 | ¥125.28 | ¥133.81 |
| Operating Margin | 5.63% | 6.55% | 7.40% | 7.73% |
| Balance Sheet | ||||
| Total Assets | ¥652,524M | ¥688,132M | ¥724,747M | ¥712,780M |
| Total Equity | ¥460,104M | ¥482,470M | ¥514,727M | ¥520,796M |
| Total Liabilities | ¥192,420M | ¥205,662M | ¥210,020M | ¥191,984M |
| Cash | ¥74,519M | ¥95,224M | ¥117,720M | ¥111,750M |
| Interest-bearing Debt | ¥22,920M | ¥21,412M | ¥20,663M | ¥2,205M |
| Equity Ratio | 70.51% | 70.11% | 71.02% | 73.07% |
| D/E Ratio | 0.05 | 0.04 | 0.04 | 0.00 |
| Cash Flow | ||||
| Operating CF | ¥39,812M | ¥64,061M | ¥63,506M | ¥81,472M |
| Investing CF | -¥15,485M | -¥19,669M | -¥22,760M | -¥20,792M |
| Financing CF | -¥20,337M | -¥23,734M | -¥18,273M | -¥66,662M |
| Free CF | ¥28,846M | ¥47,315M | ¥43,393M | ¥67,014M |
| Efficiency | ||||
| ROE | 7.47% | 8.40% | 10.17% | 10.50% |
| ROA | 5.27% | 5.89% | 7.22% | 7.67% |
Latest IR Information
-
No IR information found for this company.
Searched stock code: 3088
Latest News (5 items)
-
Average Analyst Rating: none
Average Target Price: ¥3,375
Rating Score: - (Based on 12 analysts)
※1=Strong Buy, 5=Strong Sell
Company Information
About
MatsukiyoCocokara & Co. operates and manages chain stores, drug stores, and insurance dispensing pharmacies in Japan. The company is involved in the franchise business development and product supply to franchisees. It offers its products under the nake and RECiPEO brand names. MatsukiyoCocokara & Co. was founded in 1932 and is headquartered in Tokyo, Japan.